- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Snapshot for Vivus Inc (VVUS)
| Open: | 14.0000 | Day's Range: | 13.6500 - 14.0689 | Volume: | 1,224,670 |
|---|---|---|---|---|---|
| Previous Close: | 14.0100 | 52wk Range: | 9.8600 - 31.2100 | 1-Yr Rtn: | -48.87% |
Key Statistics for VVUS
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -1.6900 |
| Est. EPS (USD) (12/2013) | -1.7640 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 1,385.95 |
| Shares Outstanding (M) | 100.72 |
| 30 Day Average Volume | 2,307,585 |
| Price/Book (mrq) | 7.8897 |
| Price/Sale (ttm) | 226.1448 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/07/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for VVUS
Company Profile & Key Executives for VVUS
VIVUS, Inc. is a biopharmaceutical company developing therapies for obesity, sleep apnea, diabetes and sexual health. The company markets a treatment for erectile dysfunction, and has drugs for obesity and erectile dysfunction in late-stage clinical trials.
| Mark B LoganChairman | Leland F WilsonChief Executive Officer |
| Peter Y TamPresident | Michael P MillerSenior VP/Chief Commercial Ofcr |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
VVUS News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page